Isoform-specific induction of PKC-ε by high glucose protects heart-derived H9c2 cells against hypoxic injury

Biochemical and Biophysical Research Communications

Volumn 309, Issue 1, 2003, Pages 1-6

  Kim, Min Hwa ^a   Jung, Yi Sook ^b   Moon, Chang Hyun ^b   Jeong, Euy Myoung ^b   Lee, Soo Hwan ^b   Baik, Eun Joo ^b   Moon, Chang Kiu ^a  

^a Seoul National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Cardioprotection; H9c2; High glucose; Hypoxia; Isoform specific; PKC

Indexed keywords

GLUCOSE; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; ENZYME INDUCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0042235278     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01525-0     Document Type: Article

References (26)

1. Malhotra A., Reich D., Reich D., Nakouzi A., Sanghi V., Geenen D.L., Buttrick P.M. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ. Res. 81:1997;1027-1033.
2. Moon C.H., Jung Y.S., Lee S.H., Baik E.J. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn. J. Physiol. 149:1999;409-415.
3. Feuvray D., Lopaschuk G.D. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc. Res. 34:1997;113-120.
4. Liu Y., Thornton J.D., Cohen M.V., Downey J.M., Schaffer S.W. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation. 88:1993;1273-1278.
5. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
6. Speechly-Dick M.E., Mocanu M.M., Yellon D.M. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ. Res. 75:1994;586-590.
7. Wang Y.P., Maeta H., Mizoguchi K., Suzuki T., Yamashita Y., Oe M. Intestinal ischemia preconditions myocardium: role of protein kinase C and mitochondrial K(ATP) channel. Cardiovasc. Res. 55:2002;576-582.
8. Webster K.A., Discher D.J., Bishopric N.H. Cardioprotection in an in vitro model of hypoxic preconditioning. J. Mol. Cell Cardiol. 27:1995;453-458.
9. Cross H.R., Murphy E., Bolli R., Ping P., Steenbergen C. Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production. J. Mol. Cell Cardiol. 34:2002;361-367.
10. 2+ and the protein kinase C-dependent activation of p42 mitogen-activated protein kinase. Endocrinology. 140:1999;1639-1648.
11. Moon C.H., Jung Y.S., Kim M.H., Park R.M., Lee S.H., Baik E.J. Protein kinase C inhibitors attenuate protective effect of high glucose against hypoxic injury in H9c2 cardiac cells. Jpn. J. Physiol. 50:2000;645-649.
12. Gray M.O., Karliner J.S., Mochly-Rosen D. A selective e-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272:1997;30945-30951.
13. Liu H., McPherson B.C., Yao Z. Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H404-H410.
14. Gwag B.J., Koh J.Y., DeMaro J.A., Ying H.S., Jacquin M., Choi D.W. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience. 77:1997;393-401.
15. Yasuda I., Kishimoto A., Tanaka S., Tominaga M., Sakurai A., Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166:1990;1220-1227.
16. Umansky S.R., Tomei L.D. Apoptosis in the heart. Adv. Pharmacol. 41:1997;383-407.
17. Cordey M., Gundimeda U., Gopalakrishna R., Pike C.J. Estrogen activates protein kinase C in neurons: role in neuroprotection. J. Neurochem. 84:2003;1340-1348.
18. Johnson J.A., Gray M.O., Chen C.H., Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J. Biol. Chem. 271:1996;24962-24966.
19. Kapor-Drezgic J., Zhou X., Babazono T., Dlugosz J.A., Hohman T., Whiteside C. Effect of high glucose on mesangial cell protein kinase C-δ and -ε polyol pathway-dependent. J. Am. Soc. Nephrol. 10:1999;1193-1203.
20. Strasser R.H., Simonis G., Schon S.P., Braun M.U., Ihl-Vahl R., Weinbrenner C., Marquetant R., Kubler W. Two distinct mechanisms mediate a differential regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia. Circ. Res. 85:1999;77-87.
21. Farese R.V., Standaert M.L., Cooper D.R. Protein kinase C downregulation? Nature. 360:1992;305.
22. Goldberg M., Zhang H.L., Steinberg S.F. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J. Clin. Invest. 99:1997;55-61.
23. Kim M.J., Kim M.Y., Lee S.H., Baik E.J., Moon C.H., Jung Y.S. The role of PKC during hypoxia in heart-derived H9c2 cells. Conf. Basic Res. 11:2003;318. (abstract).
24. Di-Capua N., Sperling O., Zoref-Shani E. Protein kinase C-epsilon is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures. J. Neurochem. 84:2003;409-412.
25. 2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease. J. Neurochem. 67:1996;317-323.
26. Akita Y. Protein kinase C-epsilon (PKC-epsilon): its unique structure and function. J. Biochem. (Tokyo). 132:2002;847-852.